Open AccessSingle-Dose Bioequivalence Study of Rivaroxaban-Containing Medicinal Products in Healthy Volunteers
Author(s) -
G. N. Gildeeva,
А. А. Чапленко,
V. I. Yurkov,
Е. С. Степанова
Publication year - 2022
Publication title -
bezopasnostʹ i risk farmakoterapii
Language(s) - English
Resource type - Journals
eISSN - 2619-1164
pISSN - 2312-7821
DOI - 10.30895/2312-7821-2022-10-3-293-301
Subject(s) - rivaroxaban , bioequivalence , medicine , pharmacokinetics , adverse effect , crossover study , pharmacology , dabigatran , warfarin , bioavailability , atrial fibrillation , alternative medicine , pathology , placebo